Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gadoxetate Sodium Enhanced Magnetic Resonance Imaging (MRI) as a Biomarker for Aggressive Prostate Cancer

NCT03960788 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT03960788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gadoxetate Sodium Enhanced Magnetic Resonance Imaging (MRI) as a Biomarker for Aggressive Prostate Cancer
Lead sponsor
University of Cincinnati
Phase
Phase 1
Overall status
Unknown status
Start date
January 2, 2018
Completion date
January 2, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the prostate, castration-resistant prostate cancer